Research and Markets: Leukemia Partnering 2009-2014

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/pdtlck/leukemia) has announced the addition of the "Leukemia Partnering 2009-2014" report to their offering.

The Leukemia Partnering 2009-2014 provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of leukemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors leukemia technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in leukemia partnering

Chapter 3 - Leading leukemia deals

Chapter 4 - Dealmaking directory

Chapter 5 - Partnering resource center

For more information visit http://www.researchandmarkets.com/research/pdtlck/leukemia

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices